Correlation of C609T Polymorphism of Nadph Quinone Oxidoreductase 1 and Hematological Toxicities in Lung Cancer Patients Treated With Amrubicin

MLA

Misato Nagata, et al. “Correlation of C609T Polymorphism of Nadph Quinone Oxidoreductase 1 and Hematological Toxicities in Lung Cancer Patients Treated With Amrubicin.” Annals of Oncology, vol. 23, Sept. 2012, p. ix92. EBSCOhost, https://doi.org/10.1016/s0923-7534(20)32803-9.

APA

Misato Nagata, Tomohiro Suzumura, Toshiyuki Nakai, S. Kudoh, Shigeki Mitsuoka, Kazuto Hirata, T. Kimura, Yukimi Kira, Kanako Umekawa, & Kuniomi Matsuura. (2012). Correlation of C609T Polymorphism of Nadph Quinone Oxidoreductase 1 and Hematological Toxicities in Lung Cancer Patients Treated With Amrubicin. Annals of Oncology, 23, ix92. https://doi.org/10.1016/s0923-7534(20)32803-9

Chicago

Misato Nagata, Tomohiro Suzumura, Toshiyuki Nakai, S. Kudoh, Shigeki Mitsuoka, Kazuto Hirata, T. Kimura, Yukimi Kira, Kanako Umekawa, and Kuniomi Matsuura. 2012. “Correlation of C609T Polymorphism of Nadph Quinone Oxidoreductase 1 and Hematological Toxicities in Lung Cancer Patients Treated With Amrubicin.” Annals of Oncology 23 (September): ix92. doi:10.1016/s0923-7534(20)32803-9.